BATS BZX Real-Time Price
| -0.32 / -0.27%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 114.00, with a high estimate of 163.00 and a low estimate of 87.00. The median estimate represents a -5.32% decrease from the last price of 120.41.
The current consensus among 8 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.